1. Home
  2. VNDA vs AEYE Comparison

VNDA vs AEYE Comparison

Compare VNDA & AEYE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VNDA
  • AEYE
  • Stock Information
  • Founded
  • VNDA 2002
  • AEYE 2005
  • Country
  • VNDA United States
  • AEYE United States
  • Employees
  • VNDA N/A
  • AEYE N/A
  • Industry
  • VNDA Biotechnology: Pharmaceutical Preparations
  • AEYE Computer Software: Prepackaged Software
  • Sector
  • VNDA Health Care
  • AEYE Technology
  • Exchange
  • VNDA Nasdaq
  • AEYE Nasdaq
  • Market Cap
  • VNDA 270.2M
  • AEYE 278.0M
  • IPO Year
  • VNDA 2006
  • AEYE N/A
  • Fundamental
  • Price
  • VNDA $5.09
  • AEYE $32.29
  • Analyst Decision
  • VNDA Strong Buy
  • AEYE Strong Buy
  • Analyst Count
  • VNDA 2
  • AEYE 4
  • Target Price
  • VNDA $15.50
  • AEYE $25.38
  • AVG Volume (30 Days)
  • VNDA 775.4K
  • AEYE 137.9K
  • Earning Date
  • VNDA 11-06-2024
  • AEYE 11-07-2024
  • Dividend Yield
  • VNDA N/A
  • AEYE N/A
  • EPS Growth
  • VNDA N/A
  • AEYE N/A
  • EPS
  • VNDA N/A
  • AEYE N/A
  • Revenue
  • VNDA $190,858,000.00
  • AEYE $32,261,000.00
  • Revenue This Year
  • VNDA $6.70
  • AEYE $13.76
  • Revenue Next Year
  • VNDA $51.03
  • AEYE $18.75
  • P/E Ratio
  • VNDA N/A
  • AEYE N/A
  • Revenue Growth
  • VNDA N/A
  • AEYE 3.91
  • 52 Week Low
  • VNDA $3.30
  • AEYE $3.91
  • 52 Week High
  • VNDA $6.75
  • AEYE $29.30
  • Technical
  • Relative Strength Index (RSI)
  • VNDA 59.66
  • AEYE 63.87
  • Support Level
  • VNDA $4.56
  • AEYE $21.15
  • Resistance Level
  • VNDA $4.89
  • AEYE $29.25
  • Average True Range (ATR)
  • VNDA 0.18
  • AEYE 1.76
  • MACD
  • VNDA 0.04
  • AEYE 0.25
  • Stochastic Oscillator
  • VNDA 66.67
  • AEYE 73.40

About VNDA Vanda Pharmaceuticals Inc.

Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products, HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS), Fanapt for the treatment of schizophrenia and PONVORY. Its other products include VHX-896, ASO Molecules, VQW-765, Tradipitant, VTR-297 and VHX-896. The majority of revenue is derived from HETLIOZ product sales.

About AEYE AudioEye Inc.

AudioEye Inc is a software solution provider delivering immediate ADA and WCAG accessibility compliance at scale. Through patented technology, subject matter expertise and proprietary processes, it is eradicating all barriers to digital accessibility, helping creators get accessible and supporting them with ongoing advisory and automated upkeep. Trusted by the ADP, Tommy Hilfiger, A360 Media, Samsung, Landry's, and others. It helps everyone identify and resolve issues of accessibility and enhance user experiences, automating digital accessibility for the widest audiences.

Share on Social Networks: